INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 216 filers reported holding INARI MED INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $308,210,972 | +11.6% | 4,712,706 | -0.8% | 0.01% | +14.3% |
Q2 2023 | $276,095,348 | +1.7% | 4,748,802 | +8.0% | 0.01% | 0.0% |
Q1 2023 | $271,433,982 | -1.4% | 4,396,404 | +1.5% | 0.01% | 0.0% |
Q4 2022 | $275,305,627 | -10.7% | 4,331,429 | +2.1% | 0.01% | -22.2% |
Q3 2022 | $308,229,000 | +13.3% | 4,243,238 | +6.1% | 0.01% | +12.5% |
Q2 2022 | $271,977,000 | -14.7% | 4,000,255 | +13.7% | 0.01% | 0.0% |
Q1 2022 | $318,930,000 | +12.6% | 3,518,646 | +13.4% | 0.01% | +33.3% |
Q4 2021 | $283,140,000 | +20.3% | 3,102,221 | +6.9% | 0.01% | 0.0% |
Q3 2021 | $235,290,000 | +0.3% | 2,901,232 | +15.4% | 0.01% | 0.0% |
Q2 2021 | $234,496,000 | +5.3% | 2,513,883 | +20.8% | 0.01% | 0.0% |
Q1 2021 | $222,598,000 | +65.6% | 2,080,362 | +35.1% | 0.01% | +50.0% |
Q4 2020 | $134,423,000 | +135.8% | 1,539,969 | +86.5% | 0.00% | +100.0% |
Q3 2020 | $57,006,000 | +130.9% | 825,929 | +62.0% | 0.00% | +100.0% |
Q2 2020 | $24,693,000 | – | 509,745 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |